In conclusion, our study highlighted the differential gene/protein expression profile after P versus X irradiation in HNSCC and potential candidate markers for prognosis, efficacy of anti-tumor treatments and new anti-tumor targets, such as VEGF-C. The gene discussed is VEGFC; the disease is head and neck squamous cell carcinoma.